Skip to main content

Anurag Relan, Chief Medical Officer and Michael Levitan, VP Investor Relations and Capital Markets will participate in a Fireside Chat on Tuesday, May 19 at 11:30 am EDT/17:30 CEST.

Pharming 2026 Annual General Meeting of Shareholders (AGM) will be held on Thursday May 28, 2026. The Notice to Convene, Explanatory Notes, Proxy and other meeting documents for the AGM can be found on the page Shareholder Meetings.

Read more

Pharming to report 2Q/1H 2026 financial results on July 30, 2026, at 07:00 CET. You can find other results on our Financial Documents page.

Pharming to report 3Q 2026 financial results on November 5, 2026, at 07:00 CET. You can find other results on our Financial Documents page.

Cookies: This website uses cookies Check the cookies page for more information Accept Decline